Hook & thesis
Clearwater Analytics (CWAN) is a classic deal-arbitrage set up right now: an announced $24.55 per-share go-private bid versus a market price near $23.46. The spread is tight, downside is capped by an agreed deal price, and there are concrete catalysts that make a clean closing more likely than not. Buying into the gap is less about predicting product wins and more about executing event-driven math.
This trade idea is straightforward: take a long position at or near $23.46, size it to fit an arbitrage sleeve of your portfolio, place a disciplined stop and target the announced $24.55 bid. If the deal closes within ~102 trading days, investors capture roughly a 4.7% absolute return, which annualizes to about 17%. The risk/reward — relative to the operational profile and the presence of new activist capital — feels asymmetric enough to justify the position for patient, event-focused accounts.
What Clearwater does and why the market cares
Clearwater Analytics provides cloud-based investment portfolio accounting, reporting and reconciliation services to institutional investors. The product is sticky: clients rely on the platform for regulatory-compliant reporting and automated data aggregation, which creates high switching costs and recurring revenue. Customers tend to be slow to churn, and net revenue retention is reported above 100% in recent disclosures, reflecting expansion within accounts.
Why that matters: the business combines SaaS-like recurring economics with regulatory stickiness. That profile supports premium multiples in good times, and it explains why private-equity buyers—Permira and Warburg Pincus in this case—would be willing to pay a control premium to take the company private.
Hard numbers underpinning the trade
- Market cap: approximately $6.93 billion.
- The agreed buyout price: $24.55 per share (public deal terms).
- Current market price: $23.46 (last trade).
- Enterprise value: about $7.63 billion; reported free cash flow: roughly $164.3 million.
- Valuation multiples: price-to-sales near 9.43, EV/sales about 10.43, EV/EBITDA around 85.4 — premium multiples consistent with high-growth SaaS-like businesses.
- Recent investor activity: Starboard Value disclosed a 4.55% stake (9.96 million shares) on 02/28/2026. Keenan Capital also initiated an $88.3 million position in Q4, reflecting institutional interest.
Those facts matter because the acquirers have already agreed to a headline valuation (roughly $8.4 billion deal value disclosed in prior commentary), and several sophisticated investors have since built stakes. The presence of recognized buyout sponsors plus activist shareholders reduces the probability of simple, execution-risk-free walkaways or major financing surprises.
Valuation framing
At face value Clearwater is an expensive company on public multiples — price-to-sales near 9.4 and EV/EBITDA north of 85 — but private-equity bids generally carry control and operational-value premia not priced into the public market. The announced purchase price implies an equity value consistent with the enterprise numbers above. In this setup the math is not about long-term multiple expansion; it's about closing the transaction at the agreed price.
Using current levels, the spread between the $24.55 bid and the $23.46 market price is about $1.09 per share (4.6% absolute). That spread compresses rapidly if the market assigns any probability to a near-term closing or a slightly higher bid driven by activist pressure or competing interest.
Catalysts
- Regulatory and shareholder approvals - final steps to consummate the go-private deal, typically the last hurdles before payment.
- Activist pressure - Starboard’s 4.55% stake (announced 02/28/2026) can push for improved disclosures or accelerate timelines, increasing the odds of a clean close.
- Competing bids or topping offers – While this is a binary risk, the presence of multiple financial sponsors in the market makes a topping offer possible and could lift the spread.
- Legal/filing completeness - public detail releases and proxy disclosures that confirm financing and timeline will tighten the spread.
Trade plan (actionable)
Entry: Buy at $23.46.
Target: $24.55.
Stop loss: $22.50.
Direction: long.
Horizon: long term (102 trading days). The expected timeline aligns with a typical go-private closing window post-announcement; using ~102 trading days produces an annualized return in the neighborhood of 17% if the deal executes at the agreed price.
Execution notes: size the position as an arbitrage sleeve — modest allocation relative to core holdings. Use the stop at $22.50 to protect against deal failure or material adverse changes; that stop assumes you prefer a conservative risk-control level rather than weather potentially temporary volatility. If the company releases definitive proxy materials or regulatory approvals that materially shorten the expected close window, consider trimming to lock gains or raising target accordingly.
Why this trade makes sense
This is event-driven, not a traditional long based on organic growth expectations. The buyer group has set a public price, institutional investors have signaled conviction by building stakes, and the gap is small enough that a clean close offers a reliable absolute return. With ~$164 million in free cash flow and a clear buyer, the deal mechanics are straightforward; the major open risks are legal or regulatory interruptions or a buyer renegotiation.
Risks and counterarguments
- Regulatory or antitrust issues: While the deal is between financial sponsors and a software company (lower antitrust profile than industrial mergers), regulatory questions or extended reviews can delay closing and compress annualized returns.
- Financing or macro shock: A financing hiccup for the private-equity buyers in a stressed credit market could derail or slow the process, widening downside. Although buyouts typically have financing commitments, markets can change quickly.
- Legal challenges by shareholder plaintiffs: Several law firms publicly announced investigations into the fairness of the $24.55 price on 03/05/2026 and 02/13/2026. Litigation or demands for supplemental disclosures can delay closing or force a revised process.
- Deal termination or renegotiation: If the buyer and seller agree to amend terms downward, the current market price could reprice to a lower negotiation level, producing losses. The $22.50 stop is designed to limit that outcome.
- Operational deterioration: If material adverse changes in Clearwater’s business occur between now and closing, the buyer could seek price protection or walk; although this is low probability, it is not zero.
Counterargument to the thesis
One could reasonably argue that given the premium multiples and negative recent EPS, shareholders should have held out for a higher price and that institutional pressure — including legal investigators — could force a better outcome than $24.55. If a topping bid emerged, the market would reprice upward and the arbitrage would flip into a momentum trade. That is a valid view, and it cuts both ways: while it could generate better returns if a higher bid arrives, it also implies more headline volatility and legal friction that could delay or imperil the transaction.
What would change my mind
- If the buyers publish a financing contingency or there are credible reports that financing terms are under stress, I would close the position and re-evaluate.
- If formal litigation materially threatens the deal structure or if a regulator signals a substantive review, I would narrow the risk and likely exit.
- If a topping bid above $24.55 appears, I would re-assess sizing and may convert to a directional long to capture upside beyond the announced price.
Conclusion
Buying Clearwater at $23.46 into a $24.55 agreed take-private price is a sensible, event-driven arbitrage for investors comfortable with deal risk. The situation combines a public, committed buyer group, activist ownership that supports deal completion (or negotiation), and a tight spread that translates into an attractive annualized return if the deal closes in the expected window. Keep position sizes measured, use the $22.50 stop to limit downside, and monitor legal and financing headlines closely. If the process proceeds smoothly, this trade should capture a modest absolute gain with a favorable annualized profile versus most cash or bond alternatives.